drugset / Trial / NCT02942602

Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia

NCT02942602 ↗

Completed 58 enrolled Yonsei University
RandomizedParallel-groupOpen-labelBasic science

Summary

1\) to test HDL function comprehensively in healthy and diseased individuals; 2) to evaluate if this test correlates with cardiovascular risk, independent of traditional risk factors; 3) and to differentiate effects of lipid-modifying or antiatherosclerotic drugs on HDL function and composition

Timeline

Start
2014-04-03
Primary completion
2016-05-23
Completion
2016-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 5 mg —
Subject Atorvastatin Small molecule 20 mg —
Subject Cholestyramine Other / unclassified 8 g —
Subject Ezetimibe Unknown 10 mg —
Subject Omega-3 fatty acids Unknown 2 g —

Indications